Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-11-08

AUTHORS

Talar Tokatlian, Daniel W. Kulp, Andrew A. Mutafyan, Christopher A. Jones, Sergey Menis, Erik Georgeson, Mike Kubitz, Michael H. Zhang, Mariane B. Melo, Murillo Silva, Dong Soo Yun, William R. Schief, Darrell J. Irvine

ABSTRACT

An HIV vaccine capable of eliciting durable neutralizing antibody responses continues to be an important unmet need. Multivalent nanoparticles displaying a high density of envelope trimers may be promising immunogen forms to elicit strong and durable humoral responses to HIV, but critical particle design criteria remain to be fully defined. To this end, we developed strategies to covalently anchor a stabilized gp140 trimer, BG505 MD39, on the surfaces of synthetic liposomes to study the effects of trimer density and vesicle stability on vaccine-elicited humoral responses in mice. CryoEM imaging revealed homogeneously distributed and oriented MD39 on the surface of liposomes irrespective of particle size, lipid composition, and conjugation strategy. Immunization with covalent MD39-coupled liposomes led to increased germinal center and antigen-specific T follicular helper cell responses and significantly higher avidity serum MD39-specific IgG responses compared to immunization with soluble MD39 trimers. A priming immunization with liposomal-MD39 was important for elicitation of high avidity antibody responses, regardless of whether booster immunizations were administered with either soluble or particulate trimers. The stability of trimer anchoring to liposomes was critical for these effects, as germinal center and output antibody responses were further increased by liposome compositions incorporating sphingomyelin that exhibited high in vitro stability in the presence of serum. Together these data highlight key liposome design features for optimizing humoral immunity to lipid nanoparticle immunogens. More... »

PAGES

16527

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41598-018-34853-2

DOI

http://dx.doi.org/10.1038/s41598-018-34853-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107991068

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30410003


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "AIDS Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Neutralizing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibody Formation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cryoelectron Microscopy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Stability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Germinal Center", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Antibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunity, Humoral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liposomes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "env Gene Products, Human Immunodeficiency Virus", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Koch Institute, MIT, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.116068.8", 
          "name": [
            "Koch Institute, MIT, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tokatlian", 
        "givenName": "Talar", 
        "id": "sg:person.01273257210.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273257210.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Vaccine and Immunotherapy Center, The Wistar Institute, Pennsylvania, USA", 
          "id": "http://www.grid.ac/institutes/grid.251075.4", 
          "name": [
            "International AIDS Vaccine Initiative, New York, USA", 
            "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA", 
            "Vaccine and Immunotherapy Center, The Wistar Institute, Pennsylvania, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kulp", 
        "givenName": "Daniel W.", 
        "id": "sg:person.014112457267.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014112457267.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Koch Institute, MIT, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.116068.8", 
          "name": [
            "Koch Institute, MIT, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mutafyan", 
        "givenName": "Andrew A.", 
        "id": "sg:person.010501256101.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010501256101.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Koch Institute, MIT, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.116068.8", 
          "name": [
            "Koch Institute, MIT, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jones", 
        "givenName": "Christopher A.", 
        "id": "sg:person.011047100070.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011047100070.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.214007.0", 
          "name": [
            "International AIDS Vaccine Initiative, New York, USA", 
            "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Menis", 
        "givenName": "Sergey", 
        "id": "sg:person.01046014240.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046014240.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.214007.0", 
          "name": [
            "International AIDS Vaccine Initiative, New York, USA", 
            "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Georgeson", 
        "givenName": "Erik", 
        "id": "sg:person.01117313061.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117313061.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.214007.0", 
          "name": [
            "International AIDS Vaccine Initiative, New York, USA", 
            "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kubitz", 
        "givenName": "Mike", 
        "id": "sg:person.01155122171.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155122171.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Koch Institute, MIT, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.116068.8", 
          "name": [
            "Koch Institute, MIT, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Michael H.", 
        "id": "sg:person.016017707275.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016017707275.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Koch Institute, MIT, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.116068.8", 
          "name": [
            "Koch Institute, MIT, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Melo", 
        "givenName": "Mariane B.", 
        "id": "sg:person.015406457577.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015406457577.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Koch Institute, MIT, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.116068.8", 
          "name": [
            "Koch Institute, MIT, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Silva", 
        "givenName": "Murillo", 
        "id": "sg:person.016217052325.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016217052325.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Koch Institute, MIT, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.116068.8", 
          "name": [
            "Koch Institute, MIT, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yun", 
        "givenName": "Dong Soo", 
        "id": "sg:person.0675401605.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675401605.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ragon Institute of MGH, MIT, and Harvard, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.461656.6", 
          "name": [
            "International AIDS Vaccine Initiative, New York, USA", 
            "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA", 
            "Immunology and Microbial Science, TSRI, California, USA", 
            "Ragon Institute of MGH, MIT, and Harvard, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schief", 
        "givenName": "William R.", 
        "id": "sg:person.01152035030.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152035030.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Howard Hughes Medical Institute, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.413575.1", 
          "name": [
            "Koch Institute, MIT, Massachusetts, USA", 
            "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA", 
            "Department of Biological Engineering and Materials Science & Engineering, MIT, Massachusetts, USA", 
            "Ragon Institute of MGH, MIT, and Harvard, Massachusetts, USA", 
            "Howard Hughes Medical Institute, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Irvine", 
        "givenName": "Darrell J.", 
        "id": "sg:person.0703726511.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703726511.97"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12977-015-0210-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004342486", 
          "https://doi.org/10.1186/s12977-015-0210-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncomms12040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014097070", 
          "https://doi.org/10.1038/ncomms12040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncomms12041", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026092800", 
          "https://doi.org/10.1038/ncomms12041"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/308457a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019446715", 
          "https://doi.org/10.1038/308457a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/5568", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010692125", 
          "https://doi.org/10.1038/5568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41467-017-01549-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092714915", 
          "https://doi.org/10.1038/s41467-017-01549-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/72318", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000728454", 
          "https://doi.org/10.1038/72318"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-11-08", 
    "datePublishedReg": "2018-11-08", 
    "description": "An HIV vaccine capable of eliciting durable neutralizing antibody responses continues to be an important unmet need. Multivalent nanoparticles displaying a high density of envelope trimers may be promising immunogen forms to elicit strong and durable humoral responses to HIV, but critical particle design criteria remain to be fully defined. To this end, we developed strategies to covalently anchor a stabilized gp140 trimer, BG505 MD39, on the surfaces of synthetic liposomes to study the effects of trimer density and vesicle stability on vaccine-elicited humoral responses in mice. CryoEM imaging revealed homogeneously distributed and oriented MD39 on the surface of liposomes irrespective of particle size, lipid composition, and conjugation strategy. Immunization with covalent MD39-coupled liposomes led to increased germinal center and antigen-specific T follicular helper cell responses and significantly higher avidity serum MD39-specific IgG responses compared to immunization with soluble MD39 trimers. A priming immunization with liposomal-MD39 was important for elicitation of high avidity antibody responses, regardless of whether booster immunizations were administered with either soluble or particulate trimers. The stability of trimer anchoring to liposomes was critical for these effects, as germinal center and output antibody responses were further increased by liposome compositions incorporating sphingomyelin that exhibited high in vitro stability in the presence of serum. Together these data highlight key liposome design features for optimizing humoral immunity to lipid nanoparticle immunogens.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41598-018-34853-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2435065", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438804", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2705345", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2435233", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1045337", 
        "issn": [
          "2045-2322"
        ], 
        "name": "Scientific Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "humoral response", 
      "antibody response", 
      "germinal centers", 
      "envelope trimer", 
      "follicular helper cell responses", 
      "HIV envelope trimer", 
      "helper cell responses", 
      "high-avidity antibodies", 
      "important unmet need", 
      "priming immunization", 
      "booster immunization", 
      "HIV vaccine", 
      "IgG responses", 
      "humoral immunity", 
      "avidity antibodies", 
      "cell responses", 
      "unmet need", 
      "gp140 trimers", 
      "immunization", 
      "nanoparticle immunogens", 
      "presence of serum", 
      "surface of liposomes", 
      "nanoparticle delivery", 
      "response", 
      "lipid composition", 
      "liposome composition", 
      "HIV", 
      "vaccine", 
      "liposomes", 
      "mice", 
      "immunity", 
      "serum", 
      "antibodies", 
      "immunogen", 
      "center", 
      "imaging", 
      "effect", 
      "delivery", 
      "synthetic liposomes", 
      "sphingomyelin", 
      "conjugation strategies", 
      "criteria", 
      "strategies", 
      "multivalent nanoparticles", 
      "presence", 
      "need", 
      "elicitation", 
      "end", 
      "features", 
      "vesicle stability", 
      "high density", 
      "form", 
      "design features", 
      "size", 
      "trimer", 
      "density", 
      "composition", 
      "stability of trimers", 
      "stability", 
      "surface", 
      "particle size", 
      "nanoparticles", 
      "design criteria", 
      "immunogen forms", 
      "durable humoral responses", 
      "critical particle design criteria", 
      "particle design criteria", 
      "BG505 MD39", 
      "MD39", 
      "trimer density", 
      "vaccine-elicited humoral responses", 
      "covalent MD39", 
      "higher avidity serum MD39-specific IgG responses", 
      "avidity serum MD39-specific IgG responses", 
      "serum MD39-specific IgG responses", 
      "MD39-specific IgG responses", 
      "soluble MD39 trimers", 
      "MD39 trimers", 
      "output antibody responses", 
      "data highlight key liposome design features", 
      "highlight key liposome design features", 
      "key liposome design features", 
      "liposome design features"
    ], 
    "name": "Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes", 
    "pagination": "16527", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107991068"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41598-018-34853-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30410003"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41598-018-34853-2", 
      "https://app.dimensions.ai/details/publication/pub.1107991068"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_793.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41598-018-34853-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-018-34853-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-018-34853-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-018-34853-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-018-34853-2'


 

This table displays all metadata directly associated to this object as RDF triples.

354 TRIPLES      22 PREDICATES      133 URIs      118 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41598-018-34853-2 schema:about N216ddea926644220a3a7602f35604c70
2 N2699b7c8b31d4b2b8f7a70257f0c6a42
3 N41c38f360a424f6cbf3d664bcce89677
4 N5b9fc0253aa44956b85433bebaaed19b
5 N6b319f975e5741ba8dc907c92fe59aad
6 N7c0e225001e94b3e958994e1da67f7ef
7 N7d83ef491e4744b49154b3ce54508cb0
8 N94370495c1534aa3b38f583aee27cb9c
9 N950da1cc602942f9b2c80280dedbf9af
10 N9e1f1dea430d402d8064f0b6efa014f6
11 Naf32477f89574f7faa71328ca7f6250a
12 Nbef8be5c2d8543a5af898605fd7f6464
13 Nc59a375ecaa9476d8b144d846cabfeab
14 Nd7e44b5f2dd14e5b839ce60195a40c5f
15 Ndcf929cbd0a84d4ead37fd2bb017e504
16 Ne60db225fe6b4323b46ef9b7f91b959b
17 Nfdc5ea5d4b674faeaf73749851441f97
18 anzsrc-for:11
19 anzsrc-for:1107
20 schema:author N98e4c59249504587acf6810c7ee5e405
21 schema:citation sg:pub.10.1038/308457a0
22 sg:pub.10.1038/5568
23 sg:pub.10.1038/72318
24 sg:pub.10.1038/ncomms12040
25 sg:pub.10.1038/ncomms12041
26 sg:pub.10.1038/s41467-017-01549-6
27 sg:pub.10.1186/s12977-015-0210-4
28 schema:datePublished 2018-11-08
29 schema:datePublishedReg 2018-11-08
30 schema:description An HIV vaccine capable of eliciting durable neutralizing antibody responses continues to be an important unmet need. Multivalent nanoparticles displaying a high density of envelope trimers may be promising immunogen forms to elicit strong and durable humoral responses to HIV, but critical particle design criteria remain to be fully defined. To this end, we developed strategies to covalently anchor a stabilized gp140 trimer, BG505 MD39, on the surfaces of synthetic liposomes to study the effects of trimer density and vesicle stability on vaccine-elicited humoral responses in mice. CryoEM imaging revealed homogeneously distributed and oriented MD39 on the surface of liposomes irrespective of particle size, lipid composition, and conjugation strategy. Immunization with covalent MD39-coupled liposomes led to increased germinal center and antigen-specific T follicular helper cell responses and significantly higher avidity serum MD39-specific IgG responses compared to immunization with soluble MD39 trimers. A priming immunization with liposomal-MD39 was important for elicitation of high avidity antibody responses, regardless of whether booster immunizations were administered with either soluble or particulate trimers. The stability of trimer anchoring to liposomes was critical for these effects, as germinal center and output antibody responses were further increased by liposome compositions incorporating sphingomyelin that exhibited high in vitro stability in the presence of serum. Together these data highlight key liposome design features for optimizing humoral immunity to lipid nanoparticle immunogens.
31 schema:genre article
32 schema:inLanguage en
33 schema:isAccessibleForFree true
34 schema:isPartOf N0b72bba9500d42f88c8b0ecab1c96fb4
35 Na358ec83326f445e88363250c2b40b2d
36 sg:journal.1045337
37 schema:keywords BG505 MD39
38 HIV
39 HIV envelope trimer
40 HIV vaccine
41 IgG responses
42 MD39
43 MD39 trimers
44 MD39-specific IgG responses
45 antibodies
46 antibody response
47 avidity antibodies
48 avidity serum MD39-specific IgG responses
49 booster immunization
50 cell responses
51 center
52 composition
53 conjugation strategies
54 covalent MD39
55 criteria
56 critical particle design criteria
57 data highlight key liposome design features
58 delivery
59 density
60 design criteria
61 design features
62 durable humoral responses
63 effect
64 elicitation
65 end
66 envelope trimer
67 features
68 follicular helper cell responses
69 form
70 germinal centers
71 gp140 trimers
72 helper cell responses
73 high density
74 high-avidity antibodies
75 higher avidity serum MD39-specific IgG responses
76 highlight key liposome design features
77 humoral immunity
78 humoral response
79 imaging
80 immunity
81 immunization
82 immunogen
83 immunogen forms
84 important unmet need
85 key liposome design features
86 lipid composition
87 liposome composition
88 liposome design features
89 liposomes
90 mice
91 multivalent nanoparticles
92 nanoparticle delivery
93 nanoparticle immunogens
94 nanoparticles
95 need
96 output antibody responses
97 particle design criteria
98 particle size
99 presence
100 presence of serum
101 priming immunization
102 response
103 serum
104 serum MD39-specific IgG responses
105 size
106 soluble MD39 trimers
107 sphingomyelin
108 stability
109 stability of trimers
110 strategies
111 surface
112 surface of liposomes
113 synthetic liposomes
114 trimer
115 trimer density
116 unmet need
117 vaccine
118 vaccine-elicited humoral responses
119 vesicle stability
120 schema:name Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
121 schema:pagination 16527
122 schema:productId N2d775339b14e43e3989334bc244b202e
123 N733c1acdde4344c4807a7eb1a565a106
124 Nb5193ccd998d4d3ca2d8ac9be513efa6
125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107991068
126 https://doi.org/10.1038/s41598-018-34853-2
127 schema:sdDatePublished 2021-12-01T19:42
128 schema:sdLicense https://scigraph.springernature.com/explorer/license/
129 schema:sdPublisher N49485762f4a44b32aab06dd96d7651b7
130 schema:url https://doi.org/10.1038/s41598-018-34853-2
131 sgo:license sg:explorer/license/
132 sgo:sdDataset articles
133 rdf:type schema:ScholarlyArticle
134 N03df0cd10a5e4afeae1f793338d3ea8a rdf:first sg:person.01152035030.60
135 rdf:rest N57271f31e7a24a86aae3bfd75cf3c8f4
136 N04ff889dab7348d5b4b30bbb0a9ed19a rdf:first sg:person.010501256101.31
137 rdf:rest N1bfab818d1d54b488c247f7c5e8f2883
138 N0b72bba9500d42f88c8b0ecab1c96fb4 schema:volumeNumber 8
139 rdf:type schema:PublicationVolume
140 N1bfab818d1d54b488c247f7c5e8f2883 rdf:first sg:person.011047100070.61
141 rdf:rest N5da0e74a0229405889146ffe1e326fac
142 N216ddea926644220a3a7602f35604c70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Liposomes
144 rdf:type schema:DefinedTerm
145 N2699b7c8b31d4b2b8f7a70257f0c6a42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Germinal Center
147 rdf:type schema:DefinedTerm
148 N289354f97a714870b4b77ed2ba3eeb25 rdf:first sg:person.016017707275.98
149 rdf:rest Nb8d398bf552343a1a14c9fcbfaba28e1
150 N2d775339b14e43e3989334bc244b202e schema:name pubmed_id
151 schema:value 30410003
152 rdf:type schema:PropertyValue
153 N31d0121ce84b408c9fdace82b9127d2c rdf:first sg:person.0675401605.59
154 rdf:rest N03df0cd10a5e4afeae1f793338d3ea8a
155 N3e6a65ba9d61403e9d138772c8dd48fa rdf:first sg:person.01155122171.29
156 rdf:rest N289354f97a714870b4b77ed2ba3eeb25
157 N41c38f360a424f6cbf3d664bcce89677 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Antibody Formation
159 rdf:type schema:DefinedTerm
160 N49485762f4a44b32aab06dd96d7651b7 schema:name Springer Nature - SN SciGraph project
161 rdf:type schema:Organization
162 N559464e192d54e1ba8d9e3259c5994ac rdf:first sg:person.016217052325.19
163 rdf:rest N31d0121ce84b408c9fdace82b9127d2c
164 N57271f31e7a24a86aae3bfd75cf3c8f4 rdf:first sg:person.0703726511.97
165 rdf:rest rdf:nil
166 N5b9fc0253aa44956b85433bebaaed19b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Mice
168 rdf:type schema:DefinedTerm
169 N5da0e74a0229405889146ffe1e326fac rdf:first sg:person.01046014240.75
170 rdf:rest Ne0395beb7887439d96fe9d0adf442736
171 N6b319f975e5741ba8dc907c92fe59aad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Immunization
173 rdf:type schema:DefinedTerm
174 N733c1acdde4344c4807a7eb1a565a106 schema:name dimensions_id
175 schema:value pub.1107991068
176 rdf:type schema:PropertyValue
177 N7c0e225001e94b3e958994e1da67f7ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Cell Line
179 rdf:type schema:DefinedTerm
180 N7d83ef491e4744b49154b3ce54508cb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Immunity, Humoral
182 rdf:type schema:DefinedTerm
183 N94370495c1534aa3b38f583aee27cb9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Animals
185 rdf:type schema:DefinedTerm
186 N950da1cc602942f9b2c80280dedbf9af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name env Gene Products, Human Immunodeficiency Virus
188 rdf:type schema:DefinedTerm
189 N98e4c59249504587acf6810c7ee5e405 rdf:first sg:person.01273257210.96
190 rdf:rest Nc6e45891325846f1b41e8153c1ffdf42
191 N9e1f1dea430d402d8064f0b6efa014f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name AIDS Vaccines
193 rdf:type schema:DefinedTerm
194 Na358ec83326f445e88363250c2b40b2d schema:issueNumber 1
195 rdf:type schema:PublicationIssue
196 Naf32477f89574f7faa71328ca7f6250a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Drug Design
198 rdf:type schema:DefinedTerm
199 Nb5193ccd998d4d3ca2d8ac9be513efa6 schema:name doi
200 schema:value 10.1038/s41598-018-34853-2
201 rdf:type schema:PropertyValue
202 Nb8d398bf552343a1a14c9fcbfaba28e1 rdf:first sg:person.015406457577.03
203 rdf:rest N559464e192d54e1ba8d9e3259c5994ac
204 Nbef8be5c2d8543a5af898605fd7f6464 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Drug Stability
206 rdf:type schema:DefinedTerm
207 Nc59a375ecaa9476d8b144d846cabfeab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Humans
209 rdf:type schema:DefinedTerm
210 Nc6e45891325846f1b41e8153c1ffdf42 rdf:first sg:person.014112457267.32
211 rdf:rest N04ff889dab7348d5b4b30bbb0a9ed19a
212 Nd7e44b5f2dd14e5b839ce60195a40c5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Nanoparticles
214 rdf:type schema:DefinedTerm
215 Ndcf929cbd0a84d4ead37fd2bb017e504 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Cryoelectron Microscopy
217 rdf:type schema:DefinedTerm
218 Ne0395beb7887439d96fe9d0adf442736 rdf:first sg:person.01117313061.98
219 rdf:rest N3e6a65ba9d61403e9d138772c8dd48fa
220 Ne60db225fe6b4323b46ef9b7f91b959b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name HIV Antibodies
222 rdf:type schema:DefinedTerm
223 Nfdc5ea5d4b674faeaf73749851441f97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Antibodies, Neutralizing
225 rdf:type schema:DefinedTerm
226 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
227 schema:name Medical and Health Sciences
228 rdf:type schema:DefinedTerm
229 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
230 schema:name Immunology
231 rdf:type schema:DefinedTerm
232 sg:grant.2435065 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-018-34853-2
233 rdf:type schema:MonetaryGrant
234 sg:grant.2435233 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-018-34853-2
235 rdf:type schema:MonetaryGrant
236 sg:grant.2438804 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-018-34853-2
237 rdf:type schema:MonetaryGrant
238 sg:grant.2705345 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-018-34853-2
239 rdf:type schema:MonetaryGrant
240 sg:journal.1045337 schema:issn 2045-2322
241 schema:name Scientific Reports
242 schema:publisher Springer Nature
243 rdf:type schema:Periodical
244 sg:person.01046014240.75 schema:affiliation grid-institutes:grid.214007.0
245 schema:familyName Menis
246 schema:givenName Sergey
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046014240.75
248 rdf:type schema:Person
249 sg:person.010501256101.31 schema:affiliation grid-institutes:grid.116068.8
250 schema:familyName Mutafyan
251 schema:givenName Andrew A.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010501256101.31
253 rdf:type schema:Person
254 sg:person.011047100070.61 schema:affiliation grid-institutes:grid.116068.8
255 schema:familyName Jones
256 schema:givenName Christopher A.
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011047100070.61
258 rdf:type schema:Person
259 sg:person.01117313061.98 schema:affiliation grid-institutes:grid.214007.0
260 schema:familyName Georgeson
261 schema:givenName Erik
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117313061.98
263 rdf:type schema:Person
264 sg:person.01152035030.60 schema:affiliation grid-institutes:grid.461656.6
265 schema:familyName Schief
266 schema:givenName William R.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152035030.60
268 rdf:type schema:Person
269 sg:person.01155122171.29 schema:affiliation grid-institutes:grid.214007.0
270 schema:familyName Kubitz
271 schema:givenName Mike
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155122171.29
273 rdf:type schema:Person
274 sg:person.01273257210.96 schema:affiliation grid-institutes:grid.116068.8
275 schema:familyName Tokatlian
276 schema:givenName Talar
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273257210.96
278 rdf:type schema:Person
279 sg:person.014112457267.32 schema:affiliation grid-institutes:grid.251075.4
280 schema:familyName Kulp
281 schema:givenName Daniel W.
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014112457267.32
283 rdf:type schema:Person
284 sg:person.015406457577.03 schema:affiliation grid-institutes:grid.116068.8
285 schema:familyName Melo
286 schema:givenName Mariane B.
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015406457577.03
288 rdf:type schema:Person
289 sg:person.016017707275.98 schema:affiliation grid-institutes:grid.116068.8
290 schema:familyName Zhang
291 schema:givenName Michael H.
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016017707275.98
293 rdf:type schema:Person
294 sg:person.016217052325.19 schema:affiliation grid-institutes:grid.116068.8
295 schema:familyName Silva
296 schema:givenName Murillo
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016217052325.19
298 rdf:type schema:Person
299 sg:person.0675401605.59 schema:affiliation grid-institutes:grid.116068.8
300 schema:familyName Yun
301 schema:givenName Dong Soo
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675401605.59
303 rdf:type schema:Person
304 sg:person.0703726511.97 schema:affiliation grid-institutes:grid.413575.1
305 schema:familyName Irvine
306 schema:givenName Darrell J.
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703726511.97
308 rdf:type schema:Person
309 sg:pub.10.1038/308457a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019446715
310 https://doi.org/10.1038/308457a0
311 rdf:type schema:CreativeWork
312 sg:pub.10.1038/5568 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010692125
313 https://doi.org/10.1038/5568
314 rdf:type schema:CreativeWork
315 sg:pub.10.1038/72318 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000728454
316 https://doi.org/10.1038/72318
317 rdf:type schema:CreativeWork
318 sg:pub.10.1038/ncomms12040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014097070
319 https://doi.org/10.1038/ncomms12040
320 rdf:type schema:CreativeWork
321 sg:pub.10.1038/ncomms12041 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026092800
322 https://doi.org/10.1038/ncomms12041
323 rdf:type schema:CreativeWork
324 sg:pub.10.1038/s41467-017-01549-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092714915
325 https://doi.org/10.1038/s41467-017-01549-6
326 rdf:type schema:CreativeWork
327 sg:pub.10.1186/s12977-015-0210-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004342486
328 https://doi.org/10.1186/s12977-015-0210-4
329 rdf:type schema:CreativeWork
330 grid-institutes:grid.116068.8 schema:alternateName Koch Institute, MIT, Massachusetts, USA
331 schema:name Koch Institute, MIT, Massachusetts, USA
332 rdf:type schema:Organization
333 grid-institutes:grid.214007.0 schema:alternateName Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA
334 schema:name Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA
335 International AIDS Vaccine Initiative, New York, USA
336 rdf:type schema:Organization
337 grid-institutes:grid.251075.4 schema:alternateName Vaccine and Immunotherapy Center, The Wistar Institute, Pennsylvania, USA
338 schema:name Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA
339 International AIDS Vaccine Initiative, New York, USA
340 Vaccine and Immunotherapy Center, The Wistar Institute, Pennsylvania, USA
341 rdf:type schema:Organization
342 grid-institutes:grid.413575.1 schema:alternateName Howard Hughes Medical Institute, Maryland, USA
343 schema:name Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA
344 Department of Biological Engineering and Materials Science & Engineering, MIT, Massachusetts, USA
345 Howard Hughes Medical Institute, Maryland, USA
346 Koch Institute, MIT, Massachusetts, USA
347 Ragon Institute of MGH, MIT, and Harvard, Massachusetts, USA
348 rdf:type schema:Organization
349 grid-institutes:grid.461656.6 schema:alternateName Ragon Institute of MGH, MIT, and Harvard, Massachusetts, USA
350 schema:name Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, California, USA
351 Immunology and Microbial Science, TSRI, California, USA
352 International AIDS Vaccine Initiative, New York, USA
353 Ragon Institute of MGH, MIT, and Harvard, Massachusetts, USA
354 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...